The Effectiveness and Value of Deflazacort and Exon-Skipping Therapies for the Management of Duchenne Muscular Dystrophy: A Summary from the Institute for Clinical and Economic Review’s New England Comparative Effectiveness Public Advisory Council

Detalles Bibliográficos
Autores principales: Agboola, Foluso, Lin, Grace A., Fluetsch, Noemi, Walton, Surrey M., Rind, David M., Pearson, Steven D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2020
Materias:
Perspectives on Value
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391264/
https://www.ncbi.nlm.nih.gov/pubmed/32223597
http://dx.doi.org/10.18553/jmcp.2020.26.4.361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391264/
https://www.ncbi.nlm.nih.gov/pubmed/32223597
http://dx.doi.org/10.18553/jmcp.2020.26.4.361

Ejemplares similares